DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Interim efficacy and safety results from the open-label Phase 2 SCOPE trial
Heather Shaw, Poulam Patel, Miranda Payne, Satish Kumar, Sarah Danson, Martin Highley, Kellati Prasad, Clare Barlow, Kate Young, Ioannis Karydis, Philippa Corrie, Maria Marples, Rebecca Lee, Robert Miller, and Lindy Durrant